NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 5,800 shares, a decrease of 24.7% from the October 31st total of 7,700 shares. Based on an average trading volume of 9,700 shares, the days-to-cover ratio is currently 0.6 days.
NovAccess Global Price Performance
Shares of NovAccess Global stock opened at $0.28 on Wednesday. The stock's fifty day moving average is $0.19 and its two-hundred day moving average is $0.21. NovAccess Global has a 52 week low of $0.10 and a 52 week high of $0.60.
Get NovAccess Global alerts:NovAccess Global Company Profile
(Get Rating)
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.Read More
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
- Three Reasons It's Time To Get Bullish On Organigram
- Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
- Why Investors Are Eating Up Restaurant Brands International
- Zoom Video Continues to Work Through Normalization
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.